However, controversial findings were reported afterward [13,14], and it has recently been proposed to “delist” STAP1 as a hypercholesterolemia gene since many people with mutations in STAP1 do not develop hypercholesterolemia [69]. This evidence concerns the gene STAP1 and Hypercholesterolemia.